Positive Press Coverage Likely to Affect UnitedHealth Group (UNH) Stock Price

News stories about UnitedHealth Group (NYSE:UNH) have trended positive recently, according to Alpha One Sentiment Analysis. Alpha One, a subsidiary of Accern, identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UnitedHealth Group earned a daily sentiment score of 0.44 on Alpha One’s scale. Alpha One also gave news headlines about the healthcare conglomerate an impact score of 76 out of 100, indicating that recent news coverage is likely to have an impact on the stock’s share price in the immediate future.

These are some of the headlines that may have effected Alpha One Sentiment Analysis’s scoring:

Shares of UnitedHealth Group (NYSE:UNH) opened at 172.59 on Friday. The firm has a market capitalization of $166.32 billion, a P/E ratio of 22.09 and a beta of 0.68. UnitedHealth Group has a 12-month low of $130.01 and a 12-month high of $176.14. The stock has a 50 day moving average of $170.26 and a 200-day moving average of $162.54.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The business had revenue of $48.72 billion for the quarter, compared to the consensus estimate of $48.21 billion. During the same period in the previous year, the company posted $1.81 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group will post $9.79 EPS for the current fiscal year.

UNH has been the subject of a number of recent analyst reports. Wells Fargo & Co reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, February 21st. Argus reissued a “buy” rating and set a $170.00 price objective on shares of UnitedHealth Group in a report on Monday, January 23rd. Deutsche Bank AG reissued a “buy” rating and set a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday. Finally, Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $187.00 price objective (up previously from $186.00) on shares of UnitedHealth Group in a report on Friday, April 21st. Two investment analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $182.65.

ILLEGAL ACTIVITY WARNING: “Positive Press Coverage Likely to Affect UnitedHealth Group (UNH) Stock Price” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2017/05/20/unitedhealth-group-unh-getting-positive-press-coverage-analysis-shows-updated-updated-updated.html.

In other news, EVP D Ellen Wilson sold 14,000 shares of the business’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the completion of the transaction, the executive vice president now owns 31,993 shares in the company, valued at $5,456,086.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,310 shares of the business’s stock in a transaction on Thursday, February 23rd. The stock was sold at an average price of $162.31, for a total value of $861,866.10. Following the completion of the transaction, the director now owns 60,175 shares of the company’s stock, valued at approximately $9,767,004.25. The disclosure for this sale can be found here. Insiders sold 40,148 shares of company stock worth $6,806,849 over the last three months. Corporate insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

12 Month Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply